Corporate Banner
Satellite Banner
Food & Beverage Analysis
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Nestlé Health Science Develops Brain Health Portfolio With New Acquisition

Published: Friday, July 20, 2012
Last Updated: Thursday, July 19, 2012
Bookmark and Share
Nestlé Health Science acquires stake in US firm Accera to support trials and rollout of Axona for Alzheimer’s Disease.

Nestlé Health Science has acquired a stake in Accera, a privately-held US-based company, which specializes in the research, development and commercialization of medical foods for neurodegenerative disorders like Alzheimer’s which affects more than 30 million people worldwide.

Accera’s key brand Axona, a medical food which is already on the market in the USA, is intended for the clinical dietary management of mild to moderate Alzheimer’s disease (AD).

“Our stake in Accera is a strategic step forward in building up our brain health portfolio,” said Nestlé Health Science President and CEO Luis Cantarell.

“Axona is an innovative medical food with a well understood mode of action and offers the potential for personalized nutrition for AD patients,” he added.

Axona’s mechanism of action
Alzheimer’s disease (AD) is the most common adult form of dementia and results in chronic and irreversible cognitive impairment. As AD progresses, the brain becomes less able to use glucose for the energy it needs.

Accera’s ongoing clinical trials show that Axona is metabolized by the liver to produce ketone bodies, which are naturally occurring compounds the brain can use as an alternative energy source.

This results in improved memory and cognitive function in mild to moderate AD patients.

Axona is already on the market in the US, prescribed to up to 30,000 people with mild to moderate Alzheimer’s.

Clinical Expertise
Nestlé has many years of experience researching the relationship between nutrition and cognitive function. It is critical that new solutions are found to manage cognitive decline, a major challenge in the public health arena, and Nestlé Health Science is well placed to contribute to this effort.

The investment in Accera by Nestlé Health Science will allow the collection of more extensive clinical data to support existing research into Axona.

“Nestlé Health Science’s investment will enable us to expand our clinical development programme and strengthen our commercial capabilities in the US,” said Accera’s President and CEO Holger Kunze.

“Longer term, it will also give us the opportunity to enlarge the geographic footprint of Axona.”

Personalized Nutrition
Nestlé Health Science, a fully owned subsidiary of Nestlé, aims to pioneer a new industry between the traditional nutrition and pharmaceutical industries through the development of science-based personalized nutritional solutions and shaping a new approach to disease prevention and management.

The decision to take a stake in Accera fits the strategic roadmap set out when Nestlé Health Science was created at the start of 2011.

Building on its core HealthCare Nutrition business, Nestlé Health Science has ambitions to address chronic conditions in the area of Gastrointestinal Health, Metabolic Health and Brain Health.

Recent Acquisitions
Nestlé Health Science has made several acquisitions and investments, which fit its strategic ambitions:
• Vitaflo, a provider of clinical nutritional solutions for infants, children and adults with genetic disorders that affect how food is processed by the body.
• CM&D Pharma Ltd., a company that specializes in the development of products for patients with chronic conditions like chronic kidney disease.
• Prometheus Laboratories, a US firm specializing in diagnostics and licensed speciality pharmaceuticals in GI and oncology.
• Vital Foods, a minority stake in a New Zealand based company that specializes in the development of kiwifruit-based solutions for gastrointestinal conditions.

Supporting Accera
Nestlé’s venture capital fund Inventages has been supporting Accera since 2004 and has a seat on its board. As part of the transaction Nestlé Health Science will also take a seat on the board.

The terms of the transaction are not being disclosed.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Apricot Kernels Pose Risk of Cyanide Poisoning
Eating more than three small raw apricot kernels, or less than half of one large kernel, in a serving can exceed safe levels. Toddlers consuming even one small apricot kernel risk being over the safe level.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
First DNA Vaccine in the EU Recommended for Use in Salmon
Clynav to protect Atlantic salmon from serious infectious disease.
Grant to Fund Million Peaks Project
The European Research Council (ERC) has awarded a prestigious Advanced Grant to Prof. Peter Schoenmakers, Prof. Albert Polman and Prof. Huib Bakker, all three of whom work at the University of Amsterdam (UvA).
Finding Inorganic Arsenic in Foodstuffs
A new European standard method to determine the content of inorganic arsenic in foodstuffs has been developed at the National Food Institute, Technical University of Denmark.
Effective Identification of Low-Gliadin Wheat Lines
Researchers have demonstrated the use of NIRS to identify low-gliadin wheat lines.
Virus Causing Tilapia Die-Offs Identified
Discovery of the virus causing Tilapia die-offs in Israel and Ecuador points the way to protecting a fish that feeds multitudes.
Interactive Maps Reveal Global Obesity
World’s obese population hits 640 million, according to largest ever study.
Eating Green Could be in Your Genes
Genetic variation uncovered that has evolved in populations that have historically favored vegetarian diets, such as in India, Africa and parts of East Asia.
Detecting Bacterial Growth in Packaged Food
New technique enables fast, accurate and noninvasive measurement of bacteria levels.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!